⌘K

Home/Filings/4/0001193125-25-318069

4//SEC Filing

Lee Tien-Li 4

Accession 0001193125-25-318069

CIK 0001774857other

View on SEC.gov Company Profile

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 8:30 PM ET

Size

5.1 KB

Accession

0001193125-25-318069

Insider Transaction Report

Form 4

Period: 2025-12-11

Aardvark Therapeutics, Inc.AARD

DirectorChief Executive Officer10% Owner

Transactions

Purchase
Common Stock
2025-12-11$14.48/sh+7,000$101,395→ 1,551,613 total

Holdings

Common Stock
(indirect: By Spouse)
1,474,028

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Aardvark Therapeutics, Inc.

CIK 0001774857

Entity typeother

Related Parties

1

filerCIK 0001940120

Filing Metadata

Form type: 4
Filed: Dec 11, 7:00 PM ET
Accepted: Dec 12, 8:30 PM ET
Size: 5.1 KB

View on SEC.gov